Key Statistics for SAPH
|Current P/E Ratio (ttm)
Relative P/E vs.
|Earnings Per Share (INR) (ttm)
|Est. EPS (INR) (03/2014)
|Est. PEG Ratio
|Market Cap (M INR)
|Shares Outstanding (M)
|30 Day Average Volume
|Dividend Indicated Gross Yield
|Cash Dividend (INR)
|5 Year Dividend Growth
|Next Earnings Announcement
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for SAPH
- Net Income (M/INR)
Shasun Pharmaceuticals Ltd. manufactures and develops active pharmaceutical ingredients and their intermediates. The Company produces ibuprofen derivatives, ranitidine and nizatidine and exports them to North America, Europe, Asia and Latin America.
More Company Profile & Key Executives for SAPH
|S Abhaya KumarManaging Director||S HariharanChief Financial Officer|
|S DevendraExecutive Director||S Vimal KumarExecutive Director|
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.